vs

Side-by-side financial comparison of Beta Bionics, Inc. (BBNX) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.

Ponce Financial Group, Inc. is the larger business by last-quarter revenue ($31.4M vs $27.6M, roughly 1.1× Beta Bionics, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -79.3%, a 115.5% gap on every dollar of revenue. On growth, Beta Bionics, Inc. posted the faster year-over-year revenue change (56.6% vs 37.6%).

Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.

Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.

BBNX vs PDLB — Head-to-Head

Bigger by revenue
PDLB
PDLB
1.1× larger
PDLB
$31.4M
$27.6M
BBNX
Growing faster (revenue YoY)
BBNX
BBNX
+19.0% gap
BBNX
56.6%
37.6%
PDLB
Higher net margin
PDLB
PDLB
115.5% more per $
PDLB
36.3%
-79.3%
BBNX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BBNX
BBNX
PDLB
PDLB
Revenue
$27.6M
$31.4M
Net Profit
$-21.9M
$10.1M
Gross Margin
59.5%
Operating Margin
-47.4%
43.6%
Net Margin
-79.3%
36.3%
Revenue YoY
56.6%
37.6%
Net Profit YoY
23.6%
245.6%
EPS (diluted)
$-0.49
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BBNX
BBNX
PDLB
PDLB
Q1 26
$27.6M
Q4 25
$32.1M
$31.4M
Q3 25
$27.3M
$26.7M
Q2 25
$23.2M
$26.5M
Q1 25
$17.6M
$24.6M
Q4 24
$22.8M
Q3 24
$20.2M
Q2 24
$20.2M
Net Profit
BBNX
BBNX
PDLB
PDLB
Q1 26
$-21.9M
Q4 25
$-13.5M
$10.1M
Q3 25
$-14.2M
$6.5M
Q2 25
$-16.9M
$6.1M
Q1 25
$-28.7M
$6.0M
Q4 24
$2.9M
Q3 24
$2.4M
Q2 24
$3.2M
Gross Margin
BBNX
BBNX
PDLB
PDLB
Q1 26
59.5%
Q4 25
59.0%
Q3 25
55.5%
Q2 25
53.8%
Q1 25
50.9%
Q4 24
Q3 24
Q2 24
Operating Margin
BBNX
BBNX
PDLB
PDLB
Q1 26
-47.4%
Q4 25
-50.2%
43.6%
Q3 25
-62.5%
32.8%
Q2 25
-85.5%
30.2%
Q1 25
-105.7%
32.5%
Q4 24
19.6%
Q3 24
15.2%
Q2 24
21.8%
Net Margin
BBNX
BBNX
PDLB
PDLB
Q1 26
-79.3%
Q4 25
-41.9%
36.3%
Q3 25
-52.1%
24.3%
Q2 25
-72.6%
23.0%
Q1 25
-162.5%
24.2%
Q4 24
14.1%
Q3 24
12.1%
Q2 24
15.8%
EPS (diluted)
BBNX
BBNX
PDLB
PDLB
Q1 26
$-0.49
Q4 25
$-0.16
$0.43
Q3 25
$-0.33
$0.27
Q2 25
$-0.39
$0.25
Q1 25
$-0.93
$0.25
Q4 24
$0.11
Q3 24
$0.10
Q2 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BBNX
BBNX
PDLB
PDLB
Cash + ST InvestmentsLiquidity on hand
$199.5M
$126.2M
Total DebtLower is stronger
$596.1M
Stockholders' EquityBook value
$271.2M
$541.5M
Total Assets
$304.4M
$3.2B
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BBNX
BBNX
PDLB
PDLB
Q1 26
$199.5M
Q4 25
$219.1M
$126.2M
Q3 25
$228.7M
$146.6M
Q2 25
$249.7M
$126.6M
Q1 25
$231.5M
$129.9M
Q4 24
$139.8M
Q3 24
$155.8M
Q2 24
$103.2M
Total Debt
BBNX
BBNX
PDLB
PDLB
Q1 26
Q4 25
$596.1M
Q3 25
$521.1M
Q2 25
$536.1M
Q1 25
$521.1M
Q4 24
$596.1M
Q3 24
$580.4M
Q2 24
$680.4M
Stockholders' Equity
BBNX
BBNX
PDLB
PDLB
Q1 26
$271.2M
Q4 25
$287.6M
$541.5M
Q3 25
$294.8M
$529.8M
Q2 25
$301.6M
$521.1M
Q1 25
$313.8M
$513.9M
Q4 24
$505.5M
Q3 24
$504.6M
Q2 24
$497.7M
Total Assets
BBNX
BBNX
PDLB
PDLB
Q1 26
$304.4M
Q4 25
$328.7M
$3.2B
Q3 25
$330.0M
$3.2B
Q2 25
$330.0M
$3.2B
Q1 25
$338.0M
$3.1B
Q4 24
$3.0B
Q3 24
$3.0B
Q2 24
$2.8B
Debt / Equity
BBNX
BBNX
PDLB
PDLB
Q1 26
Q4 25
1.10×
Q3 25
0.98×
Q2 25
1.03×
Q1 25
1.01×
Q4 24
1.18×
Q3 24
1.15×
Q2 24
1.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BBNX
BBNX
PDLB
PDLB
Operating Cash FlowLast quarter
$55.6M
Free Cash FlowOCF − Capex
$54.6M
FCF MarginFCF / Revenue
173.9%
Capex IntensityCapex / Revenue
3.1%
Cash ConversionOCF / Net Profit
5.48×
TTM Free Cash FlowTrailing 4 quarters
$74.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BBNX
BBNX
PDLB
PDLB
Q1 26
Q4 25
$-8.6M
$55.6M
Q3 25
$-8.7M
$1.4M
Q2 25
$-13.6M
$6.2M
Q1 25
$-20.0M
$13.1M
Q4 24
$7.2M
Q3 24
$-14.6M
Q2 24
$-2.6M
Free Cash Flow
BBNX
BBNX
PDLB
PDLB
Q1 26
Q4 25
$-10.5M
$54.6M
Q3 25
$-10.0M
$786.0K
Q2 25
$-15.4M
$5.9M
Q1 25
$-20.3M
$12.9M
Q4 24
$4.5M
Q3 24
$-15.0M
Q2 24
$-2.6M
FCF Margin
BBNX
BBNX
PDLB
PDLB
Q1 26
Q4 25
-32.8%
173.9%
Q3 25
-36.7%
2.9%
Q2 25
-66.2%
22.4%
Q1 25
-115.1%
52.6%
Q4 24
19.7%
Q3 24
-74.1%
Q2 24
-13.0%
Capex Intensity
BBNX
BBNX
PDLB
PDLB
Q1 26
Q4 25
5.9%
3.1%
Q3 25
4.7%
2.3%
Q2 25
7.7%
1.0%
Q1 25
1.9%
0.6%
Q4 24
11.9%
Q3 24
2.0%
Q2 24
0.3%
Cash Conversion
BBNX
BBNX
PDLB
PDLB
Q1 26
Q4 25
5.48×
Q3 25
0.21×
Q2 25
1.01×
Q1 25
2.20×
Q4 24
2.46×
Q3 24
-5.99×
Q2 24
-0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons